Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 530

1.

Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation.

Cina RA, Wikiel KJ, Lee PW, Cameron AM, Hettiarachy S, Rowland H, Goodrich J, Colby C, Spitzer TR, Neville DM Jr, Huang CA.

Transplantation. 2006 Jun 27;81(12):1677-85.

PMID:
16794534
3.

A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.

Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.

J Immunol. 1995 Nov 1;155(9):4179-88.

PMID:
7594573
4.

Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs.

Lee PW, Cina RA, Randolph MA, Goodrich J, Rowland H, Arellano R, Kim HB, Sachs DH, Huang CA.

Exp Hematol. 2005 Mar;33(3):371-9.

PMID:
15730861
5.

[Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning].

Liu LH, Sun QY, Hu KX, Huang YJ, Fan CB, Sun Z, Yao B, Guo M, Zhao CH, Ai HS.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jul;26(7):385-8. Chinese.

PMID:
16251015
7.

Engraftment of quiescent progenitors and conversion to full chimerism after nonmyelosuppressive conditioning and hematopoietic cell transplantation in miniature swine.

Lima B, Gleit ZL, Cameron AM, Germana S, Murphy MC, Consorti R, Chang Q, Down JD, LeGuern C, Sachs DH, Huang CA.

Biol Blood Marrow Transplant. 2003 Sep;9(9):571-82.

8.

NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.

Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL, Dey B, McAfee S, Spitzer TR, Sykes M.

Exp Hematol. 2003 Oct;31(10):911-23.

PMID:
14550807
9.

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.

Strober S.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. Epub 2007 Sep 10. Review.

PMID:
17827036
10.

Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning.

Gleit ZL, Fuchimoto Y, Yamada K, Melendy E, Scheier-Dolberg R, Monajati L, Coburn RC, Neville DM Jr, Sachs DH, Huang CA.

Transplantation. 2002 Dec 15;74(11):1535-44.

PMID:
12490786
11.

Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.

Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, Uchimaru K, Takahashi S, Tani K, Tojo A, Asano S.

Exp Hematol. 2004 Dec;32(12):1246-54.

PMID:
15588949
12.

Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine.

Hettiaratchy S, Melendy E, Randolph MA, Coburn RC, Neville DM Jr, Sachs DH, Huang CA, Lee WP.

Transplantation. 2004 Feb 27;77(4):514-21.

PMID:
15084927
13.

Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.

Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.

Biol Blood Marrow Transplant. 2006 Oct;12(10):1073-84.

14.
16.

Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.

Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, Barrett AJ, Childs RW.

Blood. 2001 Sep 15;98(6):1687-94.

17.

Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.

Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.

Transplantation. 2003 Jul 15;76(1):216-24.

PMID:
12865813
18.

Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.

Ploemacher RE, Johnson KW, Rombouts EJ, Etienne K, Westerhof GR, Baumgart J, White-Scharf ME, Down JD.

Biol Blood Marrow Transplant. 2004 Apr;10(4):236-45.

19.

Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.

Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Masmas TN, Dickmeiss E, Heilmann C, Vindeløv LL.

Biol Blood Marrow Transplant. 2004 May;10(5):337-46.

20.

A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.

Guo M, Sun Z, Sun QY, Han Q, Yu CL, Wang DH, Qiao JH, Chen B, Sun WJ, Hu KX, Liu GX, Liu B, Zhao RC, Ai H.

Biol Blood Marrow Transplant. 2009 Aug;15(8):930-7. doi: 10.1016/j.bbmt.2009.04.006.

Supplemental Content

Support Center